BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR) (“Cutera” or the “Company”), a leading provider of energy-based aesthetic systems for practitioners worldwide, today announced the appointment of Rohan Seth as the company’s Chief Financial Officer, effective August 10, 2020.
Mr. Seth brings to Cutera over two decades of finance and business development experience mainly in the medical device industry. Most recently, he served as VP of Finance, Global Orthopaedics Franchise at Smith & Nephew. Prior to that, he served as the Head of Finance, U.S. Surgical at Alcon Labs where he supported a capital and recurring revenue stream business for nearly four years. Prior to his time at Alcon, Mr. Seth spent nine years at Stryker Corporation where he served in various roles across the business, including as Controller of the company’s European Division.
Dave Mowry, Chief Executive Officer of Cutera, Inc. commented, “I am pleased to welcome Rohan to our Executive Team. He brings an impressive track record of driving rapid and sustained growth, building teams and processes and improving profitability in his previous leadership roles. I am confident that his experiences, process discipline, and commitment to growth make him a great fit for our team as we continue to execute against our long-term vision for Cutera.”
Mr. Seth added, “I am thrilled to join the Cutera team, and I am confident that we can continue to leverage the company’s strong portfolio and renewed commitment to innovation to capitalize on the many opportunities across the aesthetics market. I look forward to working with Dave and the entire organization to deliver continued commercial excellence and drive profitable, long-term growth while remaining strongly capitalized.”
Mr. Seth earned his Master of Business Administration from the University of Notre Dame’s Mendoza College of Business and completed his Bachelor of Commerce in Accounting and Auditing from the University of Mumbai’s M. M. K. College of Economics and Commerce. He is also a Chartered Accountant from the Institute of Chartered Accountants of India.
Brisbane, California-based Cutera is a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide. Since 1998, Cutera has been developing innovative, easy-to-use products that enable physicians and other qualified practitioners to offer safe and effective aesthetic treatments to their patients. For more information, call 1-888-4CUTERA or visit www.cutera.com.
Safe Harbor Statement
Certain statements in this press release, other than purely historical information, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These statements include, but are not limited to, Cutera’s plans, objectives, strategies, financial performance and outlook, CFO search, product launches and performance, trends, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, our actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as “may,” “could,” “seek,” “guidance,” “predict,” “potential,” “likely,” “believe,” “will,” “should,” “expect,” “anticipate,” “estimate,” “plan,” “intend,” “forecast,” “foresee” or variations of these terms and similar expressions, or the negative of these terms or similar expressions. Forward-looking statements are based on management's current, preliminary expectations and are subject to risks and uncertainties, which may cause Cutera's actual results to differ materially from the statements contained herein. These statements are not guarantees of future performance, and stockholders should not place undue reliance on forward-looking statements. There are a number of risks, uncertainties and other important factors, many of which are beyond our control, that could cause our actual results to differ materially from the forward-looking statements contained in this press release, including those described in the “Risk Factors” section of Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, the Registration Statement on Form S-8 and other documents filed from time to time with the United States Securities and Exchange Commission by Cutera. All information in this press release is as of the date of its release. Accordingly, undue reliance should not be placed on forward-looking statements. Cutera undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date they were made, or to reflect the occurrence of unanticipated events. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Cutera's financial performance for the second quarter ended June 30, 2020, as discussed in this release, is preliminary and unaudited, and subject to adjustment.